C7263
リン酸カルシウム 二塩基性
98.0-105.0%
別名:
リン酸水素カルシウム
ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
化学式:
CaHPO4
CAS番号:
分子量:
136.06
NACRES:
NA.25
PubChem Substance ID:
UNSPSC Code:
12161700
EC Number:
231-826-1
MDL number:
Application
第二リン酸カルシウムは、以下の用途に使用されています：
- 高温化学量論的焼結ヒドロキシアパタイト（sin-HA）の調製のため
- バイオ人工膵臓（BAP）を調製するためのリン酸カルシウムセメント（CPC）の成分として
- α-リン酸三カルシウム（α-TCP）の調製のためのピロリン酸カルシウム（Ca2P2O7）の生成のため
Biochem/physiol Actions
第二リン酸カルシウムは錠剤やカプセル剤の希釈に用いられる無水和物です。圧縮性、成形性および脆性破壊傾向のために賦形剤として広く使用されています。
保管分類
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Anna Diez-Escudero et al.
Tissue engineering. Part C, Methods, 23(2), 118-124 (2017-01-14)
This article presents the application of dual focused ion beam/scanning electron microscopy (FIB-SEM) imaging for preclinical testing of calcium phosphates with osteoclast precursor cells and how this high-resolution imaging technique is able to reveal microstructural changes at a level of
Kai-Chiang Yang et al.
Transplantation, 90(6), 604-611 (2010-01-06)
Fibrous tissue outgrowth and hypoxia are the major restrictions for the application of bioartificial pancreas (BAP). Accordingly, the intramedullary cavity is proposed as an implant site, and a BAP constructed of calcium phosphate cement chamber was implanted. Mouse insulinoma cells
Aditya M Kaushal et al.
Journal of pharmaceutical sciences, 100(4), 1456-1466 (2011-04-01)
Dibasic calcium phosphate occurs as an anhydrate (DCPA; CaHPO₄) and as a dihydrate (DCPD; CaHPO₄•2H₂O). Our objective was to investigate the unusual behavior of these phases. Dibasic calcium phosphate dihydrate was dehydrated in a (i) differential scanning calorimeter (DSC) in
C L Camiré et al.
Journal of biomedical materials research. Part B, Applied biomaterials, 79(1), 159-165 (2006-04-15)
Alpha phase tricalcium phosphates (alpha-TCP) were produced using a solid-state reaction method and milled for various periods of time. The resulting four materials were alpha-TCPs, ranging in crystalline content. Powders were exposed to X-ray diffraction for material identification as well
Tae-Woo Kim et al.
Tissue engineering and regenerative medicine, 17(5), 607-624 (2020-08-18)
The delivery of growth factors using a carrier system presents a promising and innovative tool in tissue engineering and dentistry today. Two of the foremost bioactive factors, bone morphogenetic protein-2 and vascular endothelial growth factor (VEGF), are widely applied using
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）